Cheung Hoi Yu
Fortune : 248 000 $ au 30/06/2026
Fortune : 248 000 $ au 30/06/2026
Cheung Hoi Yu founded Hong Kong Biotechnology Organization in 2009, where he is working as Chairman from 2009, Hai Kang Life Corp.
Ltd. in 1999, where he is working as Chief Executive Officer & Director from 2002, BIOHK Ltd. in 2009, where he is working as Director from 2019, and various other companies.
Dr. Yu also currently works at YNBY International Ltd., as Independent Non-Executive Director from 2023, Medtide, Inc., as Independent Non-Executive Director from 2024, Immvira Bioscience, Inc., as Independent Non-Executive Director from 2025, and various other companies.
Dr. Yu also formerly worked at Hong Kong Council For Testing & Certification, as Co-Chairman from 2016 to 2021, Hong Kong Science & Technology Parks Corp., as Non-Executive Director from 2011 to 2017, Chinese Neuroscience Society, as Director from 2015 to 2019, and various other companies.
Dr. Yu received his graduate degree in 1980 from the University of Saskatchewan, doctorate degree in 1984 from the University of Saskatchewan, and undergraduate degree in 1976 from the University of Saskatchewan.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/06/2026 | 20 000 ( 0,36 % ) | 248 000 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KEEN VISION ACQUISITION CORPORATION | Directeur/Membre du Conseil | 01/10/2021 |
| YNBY INTERNATIONAL LIMITED | Directeur/Membre du Conseil | 21/11/2023 |
| MEDTIDE INC. | Directeur/Membre du Conseil | 23/05/2024 |
Angenomics Ltd. | Directeur/Membre du Conseil | - |
Immvira Bioscience, Inc.
Immvira Bioscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops, manufactures and markets novel oncolytic immunotherapies and engineered exosome therapies | Directeur/Membre du Conseil | 25/06/2025 |
The Stock Exchange of Hong Kong Ltd.
The Stock Exchange of Hong Kong Ltd. Investment Banks/BrokersFinance Provides stock exchange services | Corporate Officer/Principal | 01/04/2018 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops nucleic acid drugs | Directeur/Membre du Conseil | - |
Dna-Tech Ltd. | Directeur/Membre du Conseil | - |
Hong Kong Dna Chips Ltd. | Fondateur | 01/04/2007 |
| ░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░░░░ ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 30 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
YNBY International Ltd.
YNBY International Ltd. Investment Banks/BrokersFinance Operates as a holding company whose subsidiaries provides commodities and goods trading & money lending services | Finance |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Saskatchewan
University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hong Kong University of Science & Technology
The Hong Kong University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gordon Research Conferences
Gordon Research Conferences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that organizes scientific research conferences and seminars | Commercial Services |
The Stock Exchange of Hong Kong Ltd.
The Stock Exchange of Hong Kong Ltd. Investment Banks/BrokersFinance Provides stock exchange services | Finance |
Hong Kong Science & Technology Parks Corp.
Hong Kong Science & Technology Parks Corp. Miscellaneous Commercial ServicesCommercial Services Provides research and development in fields of science and technology | Commercial Services |
The Hong Kong Chinese Importers' & Exporters' Association | |
Peking University Health Science Center
Peking University Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hong Kong Council For Testing & Certification | |
Hong Kong-Taiwan Youth Exchange Promotion Association Ltd. | |
Lingke Pharmaceutical (Hangzhou) Co., Ltd. (China)
Lingke Pharmaceutical (Hangzhou) Co., Ltd. (China) BiotechnologyHealth Technology Engages in research and development of small-molecule drugs for tumors and autoimmune diseases | Health Technology |
Hong Kong Biotechnology Organization | |
CR-CP Life Science Fund
CR-CP Life Science Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Provides discovery, pre-clinical research, clinical development and production of drugs | Health Technology |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops nucleic acid drugs | Health Technology |
Hai Kang Life Corp. Ltd.
Hai Kang Life Corp. Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare platform | Health Services |
Sirnaomics Ltd.
Sirnaomics Ltd. BiotechnologyHealth Technology Develops therapeutics for treatment of cancer and fibrosis diseases | Health Technology |
Asian Fund For Cancer Research Ltd. | |
Tiger Jade Acquisition Co.
Tiger Jade Acquisition Co. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Immvira Bioscience, Inc.
Immvira Bioscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops, manufactures and markets novel oncolytic immunotherapies and engineered exosome therapies | Health Technology |
Keen Vision Acquisition Corp.
Keen Vision Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Allia | |
Hong Kong Dna Chips Ltd. | |
Angenomics Ltd. | |
Sun Yat-Sen Cultural Foundation Ltd. | |
Dna-Tech Ltd. | |
Chinese Neuroscience Society | |
Beijing Society For Neuroscience |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national